Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein

Human Immunology

Volumn 73, Issue 2, 2012, Pages 156-163

  Yang, Xiao wei ^a,b,c,d   Tan, Ying ^a,b,c,d   Yu, Feng ^a,b,c,d   Zhao, Ming hui ^a,b,c,d  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Anti mCRP autoantibodies; Apoptosis; Complements; Lupus nephritis; SLE

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; COLLAGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT FACTOR H; IMMUNOGLOBULIN G; MODIFIED C REACTIVE PROTEIN; MODIFIED C REACTIVE PROTEIN AUTOANTIBODY; UNCLASSIFIED DRUG;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; BINDING SITE; CASE REPORT; CELL TYPE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KIDNEY CLEARANCE; LATE APOPTOTIC CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; APOPTOSIS; AUTOANTIBODIES; BLOTTING, WESTERN; C-REACTIVE PROTEIN; CELL LINE; COMPLEMENT C1Q; COMPLEMENT FACTOR H; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PHAGOCYTOSIS; PROTEIN BINDING;

EID: 84856363861     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.007     Document Type: Article

References (42)

1. Schiller M., Bekeredjian-Ding I., Heyder P., Blank N., Ho A.D., Lorenz H.M. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2008, 15:183-191.
2. Shoenfeld Y., Alarcon-Segovia D., Buskila D., et al. Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998. Semin Arthritis Rheum 1999, 29:112-130.
3. Utz P.J., Hottelet M., Schur P.H., Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997, 185:843-854.
4. Tax W.J., Kramers C., van Bruggen M.C., Berden J.H. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 1995, 48:666-673.
5. Walport M.J. Complement. First of two parts. N Engl J Med 2001, 344:1058-1066.
6. Walport M.J. Complement. Second of two parts. N Engl J Med 2001, 344:1140-1144.
7. Arnett F.C., Reveille J.D. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 1992, 18:865-892.
8. Trouw L.A., Bengtsson A.A., Gelderman K.A., Dahlbäck B., Sturfelt G., Blom A.M. C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J Biol Chem 2007, 282:28540-28548.
9. Mevorach D., Mascarenhas J.O., Gershov D., Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998, 188:2313-2320.
10. Nauta A.J., Raaschou-Jensen N., Roos A., et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003, 33:2853-2863.
11. Mold C., Gewurz H., Du Clos T.W. Regulation of complement activation by C-reactive protein. J Immunopharmacol 1999, 42:23-30.
12. Hakobyan S., Harris C.L., van den Berg C.W., et al. Complement factor H binds to denatured rather than to native pentameric C-reactive protein. J Biol Chem 2008, 283:30451-30460.
13. Bíró A., Rovó Z., Papp D., et al. Studies on the interactions between C-reactive protein and complement proteins. Immunology 2007, 121:40-50.
14. Gershov D., Kim S., Brot N., Elkon K.B. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000, 192:1353-1364.
15. de Carvalho J.F., et al. C-reactive protein and its implications in systemic lupus erythematosus. Acta Reumatol Port 2007, 32:317-322.
16. Potempa L.A., Zeller J.M., Fiedel B.A., Kinoshita C.M., Gewurz H. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 1988, 12:391-405.
17. Potempa L.A., Maldonado B.A., Laurent P., Zemel E.S., Gewurz H. Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. Mol Immunol 1983, 20:1165-1175.
18. Reefman E., Horst G., Nijk M.T., Limburg P.C., Kallenberg C.G., Bijl M. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism. Arthritis Rheum 2007, 56:3399-3411.
19. Sjöwall C., Bengtsson A.A., Sturfelt G., Skogh T. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res Ther 2004, 6:R87-R94.
20. Figueredo M.A., Rodriguez A., Ruiz-Yagüe M., et al. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. J Rheumatol 2006, 33:1980-1986.
21. Rosenau B.J., Schur P.H. Antibodies to C reactive protein. Ann Rheum Dis 2006, 65:674-676.
22. Sjöwall C., Zickert A., Skogh T.Wetterö J., Gunnarsson I. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Res Ther 2009, 11:R188.
23. Tan Y., Yu F., Yang H., Chen M., Fang Q., Zhao M.H. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions. Hum Immunol 2008, 69:840-844.
24. Shoenfeld Y., Szyper-Kravitz M., Witte T., et al. Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1108:227-239.
25. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
26. Tsujimoto M., Inoue K., Nojima S. Purification and characterization of human serum C-reactive protein. J Biochem 1983, 94:1367-1373.
27. Khreiss T., József L., Hossain S., Chan J.S., Potempa L.A., Filep J.G. Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem 2002, 277:40775-40781.
28. McGrath F.D., Brouwer M.C., Arlaud G.J., Daha M.R., Hack C.E., Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol 2006, 176:2950-2957.
29. Kishore U., Gaboriaud C., Waters P., et al. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 2004, 25:551-561.
30. Tsuchiya S., Kobayashi Y., Goto Y., et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982, 42:1530-1536.
31. Xu W., Roos A., Schlagwein N., Woltman A.M., Daha M.R., van Kooten C. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 2006, 107:4930-4937.
32. Bijl M., Reefman E., Horst G., Limburg P.C., Kallenberg C.G. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis 2006, 65:57-63.
33. Gaipl U.S., Kuenkele S., Voll R.E., et al. Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 2001, 8:327-334.
34. Mihlan M., Stippa S., Józsi M., Zipfel P.F. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell Death Differ 2009, 16:1630-1640.
35. Cervera R., Abarca-Costalago M., Abramovicz D., et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project.". Autoimmun Rev 2006, 5:180-186.
36. Cervera R., Font J., Shoenfeld Y. European Working Party on Systemic Lupus Erythematosus. European Working Party on Systemic Lupus Erythematosus: a 15-year report. Autoimmun Rev 2006, 5. 549-53.
37. Nauta A.J., Daha M.R., van Kooten C., Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol 2003, 24:148-154.
38. Ji S.R., Wu Y., Potempa L.A., Liang Y.H., Zhao J. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2006, 26:935-941.
39. Tan Y., Zhou W., Yu F., Fang Q., Yang H.Z., Zhao M.H. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Mol Immunol 2009, 46:2178-2182.
40. Okemefuna A.I., Nan R., Miller A., Gor J., Perkins S.J. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem 2010, 285:1053-1065.
41. Ji S.R., Wu Y., Zhu L., et al. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J 2007, 21:284-294.
42. Jarva H., Jokiranta T.S., Hellwage J., Zipfel P.F., Meri S. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J Immunol 1999, 163:3957-3962.